Clinical Trials Browser

Unknown × Immunoglobulin Light-chain Amyloidosis × Bortezomib × Clear all

NCT04474938 2022-05-10

Daratumumab Combined With Bortezomib and Dexamethasone in Mayo 04 Stage III Light Chain Amyloidosis

Phase 2 Unknown

Immunoglobulin Light-chain Amyloidosis

NCT04612582 2020-11-03

Comparison of BTD and BCD Based Regimens in the Treatment of AL Amyloidosis

Phase 4 Unknown

Immunoglobulin Light-chain Amyloidosis